Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: margie who wrote (2439)	10/21/1997 8:42:00 PM
From: Izzy	Read Replies (2) of 6136

Does anyone know what the estimated European sales will be (? quarterly, ? annually)? Does AGPH get all the money from the EU sales? What is the status of Canadian/Asian approval? It seems to me that the total sales will at least equal the US sales. If true, then the stock should be valued at 100+, particularly if the other AGPH drugs receive EU approval. Is my thinking OK? If it is, I'm holding on forever.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next